Inhalers for COPD provide steroids, bronchodilators, or combination drugs. The three types differ in the mechanism by which the medication is inhaled and have different instructions for use.

Medicare Part D and Medicare Advantage (Part C) plans with drug coverage typically cover inhalers for COPD. But you may still be responsible for a portion of the cost. If you have chronic ...

Green inhalers tend to be for long-acting beta-agonist preventer medication, most often used to help reduce symptoms of respiratory conditions like asthma or COPD. These must also be taken ...

Poor treatment of asthma and COPD puts a huge burden on the NHS. For example, £1 billion is spent on asthma treatment in the UK each year and represents 60,000 to 65,000 hospital admissions. In ...

Green: These inhalers tend to be for long-acting beta-agonist preventer medication, most often used to help reduce symptoms of respiratory conditions like asthma or COPD. These must also be taken ...

More information: William B Feldman et al, Comparative effectiveness and safety of single inhaler triple therapies for chronic obstructive pulmonary disease: new user cohort study, BMJ (2024).

A high-tech device that can monitor medication use and compliance has been cleared by the FDA for use with AstraZeneca’s Airsupra and Breztri inhalers. Developed by Australian medtech firm ...

In patients with chronic obstructive pulmonary disease (COPD), the first year of using single-inhaler triple therapy is associated with slightly more major adverse cardiovascular events (MACE) than ...

COPD is a progressive, irreversible inflammatory disease of the lungs that makes it difficult to breathe. Cigarette smoking is the most common cause of COPD. Common symptoms include a persistent cough ...